PrairieView Partners LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,367 shares of the healthcare conglomerate’s stock after selling 38 shares during the quarter. PrairieView Partners LLC’s holdings in UnitedHealth Group were worth $691,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $37,000. Friedenthal Financial bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth $51,000. DecisionPoint Financial LLC raised its stake in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares during the period. Finally, Highline Wealth Partners LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the company. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Oppenheimer boosted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.
UnitedHealth Group Trading Down 1.2 %
NYSE UNH opened at $527.31 on Thursday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $485.27 billion, a P/E ratio of 34.02, a P/E/G ratio of 1.45 and a beta of 0.61. The stock’s fifty day moving average price is $526.25 and its 200-day moving average price is $563.96.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
Insider Activity at UnitedHealth Group
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
- Five stocks we like better than UnitedHealth Group
- How to Calculate Inflation Rate
- Digital Turbine Roars Back—What’s Driving the Ad Tech Surge?
- How to Invest in the Best Canadian Stocks
- 6 Stocks Poised to Benefit From a Trade War in Unexpected Ways
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.